Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2025

Genmab — Februar 2025

Planlagt Fastgjort Låst Flyttet Genmab
699 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • A Offline
    A Offline
    Aaanditsgone
    wrote on sidst redigeret af
    #137

    "the prior treatment" being Hemlibra, or..?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #138

      whatever they were on before starting this trial; it is not further specified in this data; but as Hemlibra is such a dominant player in this market, i would think your guess would be correct for most patients

      1 Reply Last reply
      0
      • A Offline
        A Offline
        Aaanditsgone
        wrote on sidst redigeret af
        #139

        Time for an upward adjustment of Mim8 peak sales estimates, perhaps?

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #140

          Er det grunden til at de først sender ansøgningen i H2 2025. Det var vist tidligere nu de skulle have sendt ansøgningen.

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #141

            At de vil have børn med i godkendelsen fra start.

            1 Reply Last reply
            0
            • troldmandenT Offline
              troldmandenT Offline
              troldmanden
              wrote on sidst redigeret af
              #142

              Hvilke peak sales estimater har i set på Mim8?

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #143

                Jeg har noteret 6,4 mia dkk i 2031. Kan ikke huske, hvor jeg har tallet fra.

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GUHO
                  wrote on sidst redigeret af
                  #144

                  Citi har ligget højt på Mim8 på 1,9 mia. dollars mens konsensus skulle være 1,1. Samme artikel nævner 6,4 mia. dkk i 2031 som Bulder

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GUHO
                    wrote on sidst redigeret af
                    #145

                    Page Not Found - NPinvestor x Netposten

                    favicon

                    NPinvestor x Netposten (npinvestor.dk)

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #146

                      Helimbra solgte i 2023 for 4,7 mia $. https://finance.yahoo.com/news/hemlibra-emicizumab-sales-increase-8-055300995.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAFN6KMaKixReHe__AJhRzQORzfQmBY-WjuR584ocJwn_q8Ibw3pEEAXgR9CvT0hp04-RxR8AZs3_pCGnH80yXz1CXP-Ks2q3SLlATyV70hIzx0xetat5zg_xLXwOXN7u2UvuhZERCY2AE0p2sRV99xUzMnf02tkTrXJfvRdCS7jz

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #147

                        Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress https://hemab.com/#post-hemab-therapeutics-presents-interim-data-from-ongoing-phase-2-study-of-hmb-001-as-first-ever-prophylactic-treatment-in-glanzmann-thrombasthenia-and-preclinical-data-from-hmb-002-in-von-willebrand-dise

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          DaPhamius
                          wrote on sidst redigeret af
                          #148

                          Hvad er forventningen til regnskabet på mandag?

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gdn55
                            wrote on sidst redigeret af
                            #149

                            Mener først regnskabet kommer den 12.02, altså onsdag

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              gdn55
                              wrote on sidst redigeret af
                              #150

                              den

                              1 Reply Last reply
                              0
                              • D Offline
                                D Offline
                                DaPhamius
                                wrote on sidst redigeret af
                                #151

                                Mente også onsdag. Forventer folk opdatering på JNJ og fremtidig pipeline eller rene tal som vi for det meste kender i forvejen?

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #152

                                  we recently had a pipeline update, they will repeat that. they should give financial guidance for 2025

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #153

                                    Knock-Your-Socks-Off-News – February 2025 https://www.linkedin.com/pulse/knock-your-socks-off-news-february-2025-genmab-qlnee/

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raun
                                      wrote on sidst redigeret af
                                      #154

                                      US noteringen er i gang med at finde nye bunde 😞

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #155

                                        Wolfgang Miesbach
                                        @miesbach
                                        Excellent presentation by Dr. Sivapalaratnam #EAHAD2025, prophylactic treatment results of a phase 1/2 study using bispecific antibody HMB-001 https://x.com/miesbach/status/1887942918117167354

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #156

                                          Brian O Mahony
                                          @Brianhemophilia
                                          Sivapalaratnam #EAHAD2025 on HMB-001 trial for Glanzmanns. Encouraging data with significant reduction in treated bleeds. This is a very difficult condition with ABR up to 80. New treatment options urgently required. https://x.com/Brianhemophilia/status/1888457175405572604

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper